-
1
-
2
182 Peripheral immunological features as predictors of breast cancer chemoimmunotherapy response
Published 2023-11-01Article -
3
Reversible Myc hypomorphism identifies a key Myc-dependency in early cancer evolution
Published 2022-11-01Get full text
Article -
4
-
5
Development and testing of a polygenic risk score for breast cancer aggressiveness
Published 2023-05-01Get full text
Article -
6
Safety and efficacy of HSP90 inhibitor ganetespib for neoadjuvant treatment of stage II/III breast cancer
Published 2022-12-01Get full text
Article -
7
Ganitumab and metformin plus standard neoadjuvant therapy in stage 2/3 breast cancer
Published 2021-10-01Get full text
Article -
8
-
9